Focal segmental glomerular sclerosis can be effectively treated using an intensive B-cell depletion therapy.

Our results show that intensive B-cell depletion therapy is able to reverse the nephrotic syndrome of steroid-dependent or frequently relapsing adult patients with putatively idiopathic FSGS (i.e. with extensive podocyte effacement).